Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xueniao'an Capsule (血尿安胶囊) is a traditional Chinese medicine (TCM) capsule developed and manufactured by Leiyunshang Pharmaceutical Group (including its subsidiaries Yunnan Leiyunshang Ideal Pharmaceutical and Anhui Leiyunshang Pharmaceutical). It is formulated with four key herbal ingredients: Clerodendranthus spicatus (肾茶), Herba Cephalanoploris (小蓟), Rhizoma Imperatae (白茅根), and Cortex Phellodendri (黄柏). Xueniao'an Capsule is primarily indicated for clearing heat, promoting diuresis, cooling blood, and stopping bleeding. It is clinically used to treat hematuria (blood in urine), frequent urination, urgent urination, painful urination, and urinary tract infections caused by the accumulation of damp-heat in the lower jiao.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xueniao'an capsule.